HAYLEY LOISELLE: Open Payments
NPI 1235909003 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,243 in 82 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $984 · 2025 $2,243
Food & beverage: $2,163Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $531 |
| Regeneron Healthcare Solutions, Inc. | 9 | $332 |
| GENZYME CORPORATION | 8 | $296 |
| ABBVIE INC. | 12 | $224 |
| Amgen Inc. | 9 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $125 |
| E.R. Squibb & Sons, L.L.C. | 2 | $119 |
| Arcutis Biotherapeutics, Inc. | 4 | $74 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $55 |
| Lilly USA, LLC | 2 | $50 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, OTEZLA, SPEVIGO, Sotyktu, Zoryve, BLU-U.
Industry payments across MD — which companies pay providers there.
